The Effects of the Obesity Paradox and In-Hospital and One-Year Outcomes in Patients With ST Elevation Myocardial Infarction (STEMI): Results From a STEMI Registry

被引:0
|
作者
Sharbati, Mina [1 ]
Heidarimoghadam, Reza [1 ]
Rouzbahani, Mohammad [1 ]
Salehi, Nahid [1 ]
Montazeri, Nafiseh [1 ]
Azimivaghar, Javad [1 ]
Mahmoudi, Sousan [1 ]
Rai, Alireza [1 ]
机构
[1] Kermanshah Univ Med Sci, Hlth Inst, Cardiovasc Res Ctr, Kermanshah, Iran
关键词
Myocardial infarction; Registry; BMI; Iran; Obesity; BODY-MASS INDEX; PERCUTANEOUS CORONARY INTERVENTION; CLINICAL-PRACTICE; EXTREME OBESITY; RISK-FACTOR; DISEASE; IMPACT; ASSOCIATION; MORTALITY; WEIGHT;
D O I
10.48305/arya.2022.26592.2811
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Obesity is strongly associated with increased cardiovascular diseases (CVD) and cardiovascular risk factors, such as diabetes mellitus, hypertension, and dyslipidemia. However, numerous studies have suggested the existence of an "obesity paradox" in which overweight and mildly obese patients often exhibit a better outcome than their leaner counterparts. Therefore, this study aimed to characterize the association between BMI and in-hospital and one-year outcomes.METHODS: This hospital-based research was conducted as a part of the Kermanshah STEMI Registry. Following the application of inclusion criteria, a total of 2,397 STEMI patients were evaluated. The data were collected using a standardized case report developed by the European Observational Registry Program (EORP). Body mass index (BMI) (kg/m2) was classified into underweight (<18.5), normal weight (18.5- 24.9), overweight (25-29.9), class I/mild obese (30-34.9), and class II/extreme obese (>= 35) categories. The independent predictors of the in-hospital and one-year outcomes were assessed using multivariable logistic regression models.RESULTS: Out of the 2397 patients, 43 (1.79%) were underweight, 934 (38.97%) were normal, 1038 (43.30%) were overweight, 322 (13.43%) were class I obese, and 60 (2.50%) were class II obese. The results of the crude analysis showed that class I obesity was protective against CV death (OR 0.50; 95% CI 0.300.84), MACE3 (MI, stroke, and death) (OR 0.47; 95% CI 0.29-0.76), and MACE5 (MACE3 plus unstable angina and heart failure) (OR 0.59; 95% CI 0.44-0.79).CONCLUSIONS: Multivariate adjustment eliminated the protective effect of class I obesity against death and MACE events. Therefore, it is possible that this protective effect does not exist and instead reflects the impact of confounding variables such as age.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 50 条
  • [41] Gender differences in clinical characteristics and in-hospital and one-year outcomes of young patients with ST-segment elevation myocardial infarction under the age of 40
    Murat, Bektas
    Kivanc, Eylem
    Dizman, Rafet
    Mert, Gurbet Ozge
    Murat, Selda
    JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2021, 13 (02) : 116 - 124
  • [42] Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial infarction registry)
    Kiris, Tuncay
    Avci, Eyup
    Ekin, Tuba
    Akgun, Didar Elif
    Tiryaki, Mucahit
    Yidirim, Arafat
    Hazir, Kutluhan
    Murat, Bektas
    Yeni, Mehtap
    Altindag, Rojhad
    Gul, Sefa
    Arik, Baran
    Guzel, Tuncay
    Murat, Selda
    Oz, Ahmet
    Karabacak, Mustafa
    Aktas, Zihni
    Yildirim, Tarik
    Kilicaslan, Baris
    Ergene, Asim Oktay
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 53 (02) : 321 - 334
  • [43] ASSESSMENT OF TREATMENT & OUTCOMES OF ST SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) IN SANDEMAN PROVINCIAL HOSPITAL QUETTA, PAKISTAN
    Haq, N.
    Sehar, S.
    Nasim, A.
    VALUE IN HEALTH, 2017, 20 (05) : A258 - A258
  • [44] In-hospital and one-year outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction
    Shihara, M
    Tsutsui, H
    Tsuchihashi, M
    Tada, H
    Kono, S
    Takeshita, A
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (09): : 932 - 936
  • [45] Enoxaparin, unfractionated heparin or both in patients with ST-segment elevation myocardial infarction? Data from the Romanian registry for ST-elevation myocardial infarction (RO-STEMI)
    Tatu-Chitoiu, Gabriel
    Dorobantu, Maria
    Vinereanu, Dragos
    Sinescu, Crina
    Petris, Antoniu
    Pop, Calin
    Olariu, Codin
    Vladoianu, Mircea
    Craiu, Elvira
    Minescu, Bogdan
    Tint, Diana
    Stanciulescu, Paul
    Babes, Katalin
    CARDIOLOGY, 2009, 113 : 63 - 63
  • [46] OUTCOMES OF CORONARY ARTERY STENTING IN PATIENTS WITH METABOLIC SYNDROME FOLLOWING ST ELEVATION MYOCARDIAL INFARCTION (STEMI)
    Igbinosa, Owen
    Rizwan, Muhammad
    Opoku-Asare, Isaac
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1365 - 1365
  • [47] Differences in outcomes of patients with in-hospital versus out-of-hospital ST-elevation myocardial infarction: a registry analysis
    Stehli, Julia
    Dagan, Misha
    Dinh, Diem T.
    Lefkovits, Jeffrey
    Dick, Ron
    Oxley, Stephanie
    Brennan, Angela L.
    Duffy, Stephen J.
    Zaman, Sarah
    BMJ OPEN, 2022, 12 (03):
  • [48] Reperfusion tactics and clinical outcomes in patients with ST segment elevation myocardial infarction (STEMI). Data of Latvian registry of acute coronary syndromes
    Zakke, Ilja
    Juhnevica, Dace
    Maca, Aija
    Jegere, Sanda
    Narbute, Inga
    Mintale, Iveta
    Kumsars, Indulis
    Erglis, Andrejs
    CARDIOLOGY, 2009, 113 : 78 - 78
  • [49] Is there an influence of advanced age on the results of percutaneous coronary interventions (PCI) in patients with ST-elevation myocardial infarction (STEMI)? Results from the ALKK PCI registry
    Tielke, S.
    Mudra, H.
    Hochadel, M.
    Zeymer, U.
    Darius, H.
    Kerber, S.
    Hauptmann, K. E.
    Senges, J.
    Zahn, R.
    EUROPEAN HEART JOURNAL, 2009, 30 : 477 - 477
  • [50] bolus streptokinase and tenecteplase in ST-elevation myocardial infarction. Data from the Romanian registry for ST-elevation myocardial infarction (RO-STEMI)
    Tatu, Chitoiu Gabriel
    Ionescu, Dan Dominic
    Militaru, Constantin
    Minescu, Bogdan
    Serban, Luminita
    Datcu, Dan Mihai
    Petris, Antoniu
    Craiu, Elvira
    Burghina, Dan
    Vladoianu, Mircea
    CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 : S19 - S19